Trial Profile
A study to investigate the efficacy and safety of Endostar (endostatin) in combination with chemoradiotherapy in patients with locally advanced nasopharyngeal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 01 Sep 2015 New trial record